Healthcare -
Biotechnology - NASDAQ - US
$ 3.28
3.8 %
$ 281 M
Market Cap
-0.86
P/E
AMLX - COST OF REVENUE
Cost of Revenue AMLX - Amylyx Pharmaceuticals, Inc.
25.4 M
LAST VALUE
2111.90%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR